Business Wire

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
TipRanks on MSN

Twist Bioscience price target raised to $42 from $34 at Evercore ISI

Evercore ISI raised the firm’s price target on Twist Bioscience (TWST) to $42 from $34 and keeps an Outperform rating on the shares. Recovering ...
Business Insider

Buy Rating Justified: Twist Bioscience’s Strong Demand and Strategic Expansion Signal Market Share Growth

Catherine Ramsey Schulte, an analyst from Robert W. Baird, maintained the Buy rating on Twist Bioscience (TWST – Research Report). The associated price target is $38.00. Catherine Ramsey Schulte’s ...
Nasdaq

What's Next: Twist Bioscience's Earnings Preview

Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2025-05-05. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Barclays keeps its overweight rating on Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation (NASDAQ: TWST) is among the 12 Best Genomics Stocks to Invest In.
Nasdaq

Where Twist Bioscience Stands With Analysts

5 analysts have shared their evaluations of Twist Bioscience (NASDAQ:TWST) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their ...
Seeking Alpha

Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, ...
Business Wire

Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Seeking Alpha

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Benzinga.com

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

On Monday, Twist Bioscience Corporation (NASDAQ:TWST) reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents. Twist Bioscience reported fourth-quarter sales of ...
Morningstar

Twist Bioscience to Present at Upcoming Investor Conferences

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...